Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis
- 29 February 1996
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 64 (2) , 179-183
- https://doi.org/10.1016/0165-5728(95)00169-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Passive transfer of seronegative myasthenia gravis to miceMuscle & Nerve, 1994
- Functional autoimmune epitope on α1-adrenergic receptors in patients with malignant hypertensionThe Lancet, 1994
- Myasthenia GravisNew England Journal of Medicine, 1994
- Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell linePflügers Archiv - European Journal of Physiology, 1994
- Autoantibodies against the High-Affinity IgE Receptor as a Cause of Histamine Release in Chronic UrticariaNew England Journal of Medicine, 1993
- Calcitonin Gene—Related Peptides and Neuromuscular InteractionsAnnals of the New York Academy of Sciences, 1992
- β2-Adrenergic receptor antibodies in myasthenia gravisJournal of Autoimmunity, 1992
- Acetylcholine regulation of nicotinic receptor channels through a putative G protein in chick myotubes.The Journal of Physiology, 1987
- Agents that activate protein kinase C reduce acetylcholine sensitivity in cultured myotubes.The Journal of cell biology, 1985
- ß-Adrenergic Receptor Activation Increases Acetylcholine Receptor Number in Cultured Skeletal Muscle MyotubesJournal of Neurochemistry, 1983